Experiment Detail



Experiment IDEXP00252
ReferenceTitle: Complementary strand microRNAs mediate acquisition of metastatic potential incolonic adenocarcinoma.
Author: Chen DT, Hernandez JM, Shibata D, McCarthy SM, Humphries LA, Clark W, Elahi A,Gruidl M, Coppola D, Yeatman T.
Journal: J Gastrointest Surg. 2012 May;16(5):905-12; discussion 912-3. doi:10.1007/s11605-011-1815-0. Epub 2012 Feb 24.
Abstract: BACKGROUND: Altered expression of specific microRNAs (miRNA) is known to occurduring colorectal carcinogenesis. However, little is known about the genome-wide alterations in miRNA expression during the neoplastic progression of primarycolorectal cancers.METHODS: Using a miRNA array platform, we evaluated the expression of 668 miRNAin primary colonic adenocarcinomas. Biological functions of selected miRNA wereevaluated with in vitro invasion assays.RESULTS: RNA was extracted for miRNA analysis from 65 primary colon cancers. Weidentified a seven-miRNA expression signature that differentiated stage I andstage IV primary colon cancers. We then demonstrated this signature was able todiscriminate between stage II and III primary colon cancers. Six differentiallyexpressed miRNA were downregulated in association with the development ofmetastases, and all 7 miRNA were complementary strand miRNA. We transfectedHCT-116, a highly invasive colon cancer cell line, with correspondingdownregulated miRNA and demonstrated that overexpression of three miRNA(miR200c*, miR143*, and miR424*) significantly abrogated invasive potential.CONCLUSION: We have identified a seven-miRNA signature that is associated withmetastatic potential in the primary tumor. Forced overexpression of threedownregulated miRNA resulted in attenuation of in vitro invasion, suggestingdirect tumor suppressive function and further supporting the biologicalimportance of complementary strand miRNA.
PMID: 22362069
Expressiion ProfileDescription: Complementary Strand MicroRNAs Mediate Acquisition of Metastatic Potential in Colonic AdenocarcinomamRNA and microRNA profile in colon cancer
Organism: Homo sapiens
GEO ID: GSE29622
Platform: GPL11162
Number of samples: 65
Design and SampleCancer Type: colon cancer
Cancer SubType: N/D
Cell Line: N/D
Experimental Design: metastasis
Case Sample: metastatic colon cancer
Control Sample: primary colon cancer
Num of Case: 18
Num of Control: 46
Quantification Software: Limma
Num of miRNAs: 577
IdentificationNum of Up: 1
Num of Down: 0